文献速递胃肠外科围术期管理与 ERAS

机器人减重手术治疗超级肥胖与超超级肥胖患者的围术期结局与麻醉考量

Perioperative outcomes and anesthetic considerations of robotic bariatric surgery in a propensity-matched cohort of super obese and super-super obese patients.
PubMed 文献 · Surg Endosc · 2018-05-15

该研究基于2015–2017年前瞻性数据库,采用倾向性评分1:2匹配,比较47例超级肥胖(BMI≥50)与94例病态肥胖患者行机器人减重手术的结局。匹配后两组基线无差异,手术方式以袖状胃切除为主,围术期并发症、再入院及手术时间均无差异,超级肥胖组住院时间略短。超超级肥胖亚组(n=11)无术中并发症、中转开腹或术后并发症。

要点

  • 机器人减重手术在超级肥胖患者中围术期并发症低,手术时间未增加。
  • 超级肥胖与病态肥胖患者匹配后并发症和再入院无差异。
  • 超超级肥胖亚组无术中并发症、中转开腹或术后并发症。

核心结论

  • 机器人减重手术可安全用于超级肥胖或超超级肥胖患者,围术期并发症低且手术时间未增加。

研究设计与样本

  • 回顾性分析2015–2017年前瞻性维护数据库,纳入连续行机器人减重手术的患者。
  • 采用1:2最近邻倾向性评分匹配控制基线特征和手术类型,最终分析47例超级肥胖与94例病态肥胖患者。

主要发现

  • 匹配后两组年龄、ASA评分及术前合并症无差异。
  • 两组袖状胃切除(81% vs 76%)与Roux-en-Y胃旁路术(13% vs 18%)比例无差异(p=0.66)。
  • 两组手术时间、术中并发症、术后并发症及再入院均无差异。
  • 病态肥胖组住院时间略长(2.2天,IQR 1.8–3.2 vs 1.8天,IQR 1.2–2.7;p=0.01)。
  • 超超级肥胖亚组(n=11,中位BMI 67,范围60–92)无手术时间延长、术中并发症、中转开腹或术后并发症。

临床怎么用

  • 对超级肥胖及超超级肥胖患者,机器人减重手术可作为安全可行的选择,围术期并发症风险低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of the robotic platform has not been well established in patients with super obesity (SO; body mass index, BMI ≥ 50) and super-super obesity (SSO, BMI ≥ 60). We aimed to determine safety and feasibility of robotic bariatric surgery in this cohort. METHODS: Review of a prospectively maintained database was performed of consecutive patients undergoing robotic bariatric surgery between 2015 and 2017. Propensity score analysis with 1:2 nearest neighbor matching was performed to control for baseline characteristics and procedure type. RESULTS: A propensity-matched cohort of 47 SO patients (median BMI 55.3, range 50.1-92.5) and 94 morbidly obese (MO; median BMI 41.8, range 35.1-48.8) patients were analyzed. After matching, there were no difference in baseline characteristics including age, American Society of Anesthesiologists (ASA) score, or preoperative comorbidities. Most patients in each group underwent sleeve gastrectomy (81% of SO patients versus 76% of MO patients) or Roux-en-Y gastric bypass (13% vs. 18%, respectively), p = 0.66. There were no differences in operative time, intraoperative complications, postoperative complications, or re-admissions between groups. Length of stay was slightly longer in the MO group (2.2 days, IQR 1.8-3.2 vs. 1.8 days, IQR 1.2-2.7; p = 0.01). A subset of SSO patients (n = 11, median BMI 67, range 60-92) was analyzed; there was no increase in operation time, and zero intraoperative complications, conversions to open, or postoperative complications in this subset. CONCLUSIONS: Robotic bariatric surgery can safely be performed on patients with SO or SSO with low perioperative morbidity and no increase in operating time.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Gray KD, Pomp A, Dakin G, et al. Perioperative outcomes and anesthetic considerations of robotic bariatric surgery in a propensity-matched cohort of super obese and super-super obese patients. Surg Endosc. 2018. PMID: 29766309. doi:10.1007/s00464-018-6241-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。